AOTMiT: Transparency Council will look into RSV vaccination, anaphylaxis and hypertension, among other issues

Agenda:

1. Preparation of a position paper on the evaluation of the drug Arexvy
   Vaccine against respiratory syncytial virus (RSV)
   Indication: active immunization for the prevention of lower respiratory tract disease caused by RSV in adults aged 65 years and older with additional risk factors such as:
   
   • chronic lung disease,
   • chronic heart disease,
   • post-stroke condition,
   • diabetes,
   • Chronic renal failure,
   • chronic liver failure.

1. Preparation of a position paper on the evaluation of the drugs EpiPen Jr., EpiPen Senior (epinephrinum)
   Indication: emergency treatment of severe allergic reactions (anaphylaxis) to:
   
   • Stings or insect bites,
   • FOOD,
   • drugs,
   • other allergens,
     and also in idiopathic or exercise-induced anaphylaxis.

1. Preparation of an opinion on the draft health policy program of JST
   Program title: Program of physiotherapeutic patronage visits in the municipality of Trzebownisko from 2025 to 2029.
2. Preparation of an opinion on the draft health policy program of JST
   Program title: Health policy program for early detection of overweight/obesity, metabolic syndrome and hypertension in children of the Municipality of Krakow.
3. Preparation of opinions for active substances:
   
   • Spironolactonum
   • Goserelinum
   • Leuprorelinum
   • Triptorelinum
     Indication: F64.0 - Transphobia.

1. Preparation of an opinion for the active substance:
   
   • Telmisartanum + amlodipini besilas + hydrochlorothiazidum
     Indication: hypertension in adults, in cases other than those specified in the Summary of Product Characteristics (SmPC).

1. Preparation of an opinion for the active substance:
   
   • Valsartanum + indapamidum
     Indication: hypertension in adults, in cases other than those specified in the SmPC.

Source: AOTMiT